Sensei Biotherapeutics, Inc. Common Stock

SNSE XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

22M

Short interest (May 15)

60.8%

Net Short (Jun 03 ): -0.1%

Borrow Fee

97.71%

↓ 7.1%

Available Shares

30K

↑ 15.1%

Price Chart

Company Overview

Sensei Biotherapeutics Inc is a clinical-stage biotechnology company engaged in the development of therapies targeting cancer through multi-node inhibition of oncogenic pathways. The company's lead program, PIKTOR, is an investigational oral combination therapy designed to inhibit multiple nodes of the PI3K/AKT/mTOR pathway and is being evaluated for the treatment of endometrial and breast cancers. In addition, the company is advancing other pipeline programs targeting tumor metabolism and signaling pathways.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001829802

Asset Type: CS

Market Data

Market Cap: $21,598,540

Employees: 29

Status: Active

Short Interest

Current Borrow Fee 97.71%

Range: 97.64% - 114.59%

Available Shares 30K

Range: 20K - 50K

Recent Changes

Fee Change: ↑ 9.1%

Available Change: ↓ 42.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime